Loading…
Attending this event?
Monday, June 17 • 11:00am - 12:00pm
#115: From Intention to Action: Building Diversity, Equity, and Inclusion Initiatives to Create a Culture of Belonging

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session
Level: Basic

It is well understood that diversity in the workplace contributes to innovation and improved business outcomes. Interweaving diversity, equity, and Inclusion (DEI) strategies into the work of an organization can improve performance and create thriving workplace cultures. Building such a culture translates into a sense of belonging that inspires employees across the pharmaceutical industry to be more engaged, considering their organization a great place to work and committing to the company mission. While most companies include DEI in their strategic plans, there remains a disconnect between having DEI as a company priority and the actual cultivation of an inclusive workplace. DEI efforts at many companies are limited to only passive learning (e.g., online modules and training) and a shift to a more engaging, fit-for-purpose approach is needed. In this session, we will share case studies of ongoing diversity, equity, and inclusion (DEI) workplace initiatives and we will delve into concrete action plans to translate DEI company priorities.

Learning Objectives

Describe existing diversity, equity, and inclusion (DEI) policies within the workplace to identify strengths and gaps; Discuss DEI initiatives that foster a culture of belonging in the workplace.

Chair

Ruth Milena Gómez Vargas, MS

Speaker

Case Study: Medical Writing Inclusion, Diversity, and Equity Alliance
Ruth Milena Gómez Vargas, MS

Case Study
Xoli Belgrave, MSc

Case Study
Carlos Orantes, MBA



Speakers
avatar for Xoli Belgrave

Xoli Belgrave

Senior Director, Head of Patient Inclusion, Parexel, United Kingdom
Xoli has been leading Clinical Trial DEI at Parexel since July 2022. As the Head of Patient Diversity, Equity & Inclusion, she helps customers build a DEI strategy and partners with Clinical Development to operationalize. Xoli has 20+ years of global clinical research experience in... Read More →
avatar for Carlos Orantes

Carlos Orantes

Chief Executive Officer, Alcanza Clinical Research, United States
RG

Ruth Gómez Vargas

Senior Medical Writer, Merck & Co., Inc., Colombia
Ruth Gómez, M.Sc., is a Regulatory Medical Writer at Merck & Co, with 14 years of experience in scientific research. She has had the opportunity to work across various fields, which has given her a profound appreciation for the power of diversity. At Merck & Co, a whole world of... Read More →


Monday June 17, 2024 11:00am - 12:00pm PDT
Room 8 San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA
  13: ProfDevelopment, Session